Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Versus Therapeutic Caffeine for Apnea of Prematurity
NCT02677584Completed
- Sponsor
- Mansoura University Children Hospital
- Start
- Mar 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of caffeine in apnea of prematurity (AOP) (2 arms), sponsored by Mansoura University Children Hospital. Primary endpoint: Duration of Respiratory Support at 60 days. Started Mar 2015; status: completed.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT02677584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02677584.